Who are Biological Vaccine VLA1553's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): HAVpur Junior, two doses enterovirus 71 vaccine, EV71 vaccine, Healive® Lot 3, 2wIPV+1sIPV, EV71 (inoculation vaccine).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/biological-vaccine-vla1553.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Biological Vaccine VLA1553 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biological Vaccine VLA1553 (Biological Vaccine VLA1553) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine Chikungunya virus structural and non-structural antigens Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Biological Vaccine VLA1553 (Biological Vaccine VLA1553) — Valneva Austria GmbH. VLA1553 is an inactivated chikungunya virus vaccine that stimulates the immune system to produce antibodies and cellular immunity against chikungunya virus infection.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Biological Vaccine VLA1553 TARGET	Biological Vaccine VLA1553	Valneva Austria GmbH	phase 3	Inactivated viral vaccine	Chikungunya virus structural and non-structural antigens
HAVpur Junior	HAVpur Junior	Crucell Holland BV	marketed	Inactivated viral vaccine	Hepatitis A virus (HAV)
two doses enterovirus 71 vaccine	two doses enterovirus 71 vaccine	Beijing Chaoyang District Centre for Disease Control and Prevention	marketed	inactivated viral vaccine	Enterovirus 71 viral antigens
EV71 vaccine	EV71 vaccine	Sinovac Biotech Co., Ltd	marketed	inactivated viral vaccine
Healive® Lot 3	Healive® Lot 3	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Hepatitis A virus surface antigens
2wIPV+1sIPV	2wIPV+1sIPV	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Poliovirus types 1, 2, and 3 antigens
EV71 (inoculation vaccine)	EV71 (inoculation vaccine)	Shandong Province Centers for Disease Control and Prevention	marketed	inactivated viral vaccine	Enterovirus 71 (EV71) viral antigens

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

Sinovac Biotech Co., Ltd · 9 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
GlaxoSmithKline · 5 drugs in this class
Valneva Austria GmbH · 4 drugs in this class
Medical University of Vienna · 3 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
China National Biotec Group Company Limited · 2 drugs in this class
Statens Serum Institut · 2 drugs in this class
Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
Crucell Holland BV · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Biological Vaccine VLA1553 — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-vaccine-vla1553. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab